Global Biosimilar Markets: Europe vs United States - How Regulation and Adoption Diverge
Europe adopted biosimilars early with clear rules and high adoption. The US lagged due to patents and regulatory hurdles-but is now catching up fast. Here's how the two markets differ and why it matters for patients and costs.
